Earnings | BDH Industries Ltd. (NSE: BDH): Q4FY23 Results Out; Total Income rises 77% YoY.

BDH Industries Ltd. is a manufacturing company that specializes in the production of therapeutic formulations, encompassing a wide range of pharmaceutical products. With a focus on healthcare, the company is dedicated to developing and manufacturing high-quality medicines to cater to diverse medical needs. BDH Industries Ltd. plays a crucial role in the pharmaceutical industry, providing a comprehensive portfolio of therapeutic formulations to support healthcare professionals and patients alike. Their commitment to quality, innovation, and customer satisfaction positions them as a trusted player in the market, contributing to the improvement of healthcare outcomes and the well-being of individuals.

• BDH Industries Ltd. reported Total Income for Q4 FY23 of ₹23 Crore up from ₹13 Crore year on year, a growth of 77%.
• Total Expenses for Q4 FY23 of ₹20 Crore up from ₹17 Crore year on year, a growth of 17%.
• Consolidated Net Profit of ₹ 1.91 Crore, up 1.6% from ₹1.88 Crore in the same quarter of the previous year. 
• The Earnings per Share is ₹3.32, up 1.2% from ₹3.28 in the same quarter of the previous year.